Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model KJ Janczura, CH Volmar, GC Sartor, SJ Rao, NR Ricciardi, G Lambert, ... Proceedings of the National Academy of Sciences of the United States of …, 2018 | 192 | 2018 |
Sexual dimorphism in the 3xTg-AD mouse model and its impact on pre-clinical research JL Dennison, NR Ricciardi, I Lohse, CH Volmar, C Wahlestedt Journal of Alzheimer's disease 80 (1), 41-52, 2021 | 62 | 2021 |
Novel approach reveals genomic landscapes of single-strand DNA breaks with nucleotide resolution in human cells H Cao, L Salazar-García, F Gao, T Wahlestedt, CL Wu, X Han, Y Cai, ... Nature communications 10 (1), 5799, 2019 | 50 | 2019 |
Emerging technologies for genome-wide profiling of DNA breakage MJ Rybin, M Ramic, NR Ricciardi, P Kapranov, C Wahlestedt, Z Zeier Frontiers in genetics 11, 610386, 2021 | 13 | 2021 |
A novel knockout mouse model of the noncoding antisense Brain-Derived Neurotrophic Factor (Bdnf) gene displays increased endogenous Bdnf protein and improved memory function … F Modarresi, RP Fatemi, SF Razavipour, N Ricciardi, M Makhmutova, ... Heliyon 7 (7), 2021 | 10 | 2021 |
Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer’s Disease Models NR Ricciardi, F Modarresi, I Lohse, NS Andrade, IR Newman, JM Brown, ... Molecular neurobiology 60 (8), 4811-4827, 2023 | 2 | 2023 |
Benefits of a novel highly bioavailable resveratrol formulation, JOTROL, for Alzheimer’s disease: Nonhuman/Lead optimization studies CH Volmar, J Dennison, NR Ricciardi, KJ Janczura, BR Walker, JM Brown, ... Alzheimer's & Dementia 16, e046267, 2020 | 2 | 2020 |
Hormesis as a Therapeutic Mechanism in Alzheimer’s Disease and Memory Formation NR Ricciardi University of Miami, 2024 | | 2024 |
A new strategy for Alzheimer’s disease: low‐dose combination of radiotherapy and pharmacological epigenetic perturbation CH Volmar, NR Ricciardi, F Modarresi, I Lohse, NS Andrade, IR Newman, ... Alzheimer's & Dementia 19, e074900, 2023 | | 2023 |
The Beneficial Role of Exercise Induced Neuronal DNA Damage NR Ricciardi, CH Volmar, C Wahlestedt Alzheimer's Association International Conference, 2022 | | 2022 |
JOTROL, a More Bioavailable Formulation of Resveratrol, Shows Potential in Targeting Alzheimer's Disease-Related Pathology J Dennison, CH Volmar, K Janczura, N Ricciardi, B Walker, MA Hayward, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 388-388, 2019 | | 2019 |
Radio-Pharmacologic Perturbation of Alzheimer's Disease Hallmarks N Ricciardi, CH Volmar, F Modarresi, N Andrade, I Lohse, K Janczura, ... NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 388-389, 2019 | | 2019 |